In partnership with the American Cancer Society, we will be participating in the ACS’s latest large cohort Cancer Prevention Study by enrolling patients at the University of Chicago Medicine Comprehensive Cancer Center, 5841 S Maryland Ave., in the Goldblatt Lobby on Thursday, Aug. 8th from 8am-11:30am.
The ACS’s Epidemiology Research Program is inviting men and women between 30 and 65 with no personal history of cancer to be a part of this historic study.
The goal for the University of Chicago Medicine is to enroll 200 individuals, helping to meet the ACS’s target of at least 300,000 adults from various racial/ethnic backgrounds from across the U.S.
The purpose of CPS-3 is to better understand the lifestyle, behavioral, environmental and genetic factors that cause or prevent cancer and to ultimately eliminate cancer as a major health problem for this and future generations. Watch a video here and learn more about this study.
Those who wish to participate will complete a brief questionnaire and provide a waist circumference and blood sample at enrollment.
In addition, participants will complete a detailed baseline exposure questionnaire. Follow-up questionnaires will be completed periodically thereafter to collect additional exposure information and ascertain incident cancer cases.
CPS-3 participants will be followed up for cancer incidence and mortality for at least 20 years, in order to study how a wide range of lifestyle, medical, environmental, genetic, and other factors can cause or prevent cancer.
The previous large study, CPS-II, has more than one million participants who have been followed for more than 20 years. To date, there have been more than 300 scientific publications stemming from this study.